Neurovalens logo — We develop non-invasive neurostimulation products used to
so...

Neurovalens

We develop non-invasive neurostimulation products used to solve some of the world’s greatest health challenges

Founded 2013 United Kingdom United Kingdom 30 employees Series Unknown Total: $15.76M Biotechnology, Health Care +1

General Information

Company Name Neurovalens
Founded Year 2013
Location United Kingdom United Kingdom +1
Employees 30
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series Unknown
Social

Get notified when Neurovalens moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neurovalens

Neurovalens is a UK-based health-tech startup that has been making waves in the biotechnology and healthcare industries since its establishment in 2013. Its flagship product, Modius, utilizes non-invasive neurostimulation to aid weight loss, addressing a significant health challenge. The company has garnered substantial recognition, winning prestigious accolades such as the 2018 CES Innovation Award and the 2019 Future Planet Awards in the Health Category. Their success has also been noted by investors, with the latest funding round of £2.10M from UK Investors in an undisclosed Series Unknown investment on 08 April 2024. Neurovalens has not only made its mark through innovation but also by gaining industry acclaim, securing the titles of Start-Up of the Year at the 2018 Digital DNA Awards and Innovative Business of the Year at the 2018 BEFTA Awards. The startup's impressive growth and accolades position it as an attractive investment opportunity in the ever-evolving healthcare technology landscape, with its potential to address pressing global health concerns.

Taxonomy: neurostimulation, health tech, non-invasive products, weight management, neuro-technology, innovation, start-up, award-winning, CES Innovation Award, technology, disruptive tech, investment, entrepreneurship

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 9
Investor Investor Investor Investor Investor Investor Investor Investor
•••• ••••
08 Apr 2024
Non Equity Assistance •••••• 1
Investor
07 Jun 2022
Grant •••••• 1
Investor
02 Dec 2021
Series A •••••• 6
Investor Investor Investor Investor Investor
•••• ••••
20 Jul 2020
Venture Round •••••• - 15 Oct 2019

View All 9 Funding Rounds

Neurovalens Alternatives & Competitors

Neurovalens vs
Sharesight
Sharesight Australia

Award-winning investment portfolio tracking software.

Seed
45 employees
Finance, Financial Services
Neurovalens vs
The Bee Corp
The Bee Corp United States

Helping growers and beekeepers measure and communicate pollination value through infrared image anal...

Series Unknown
2 employees
Analytics, AgriTech
Neurovalens vs
iSource Group
iSource Group United Kingdom

Creating tech recruitment success stories throughout the UK and continental Europe for over a decade...

29 employees
Human Resources

FAQ About Neurovalens

We develop non-invasive neurostimulation products used to solve some of the world’s greatest health challenges
Neurovalens was founded in 2013.
Neurovalens is headquartered in United Kingdom.
Neurovalens operates in the following industries: Biotechnology, Health Care, Life Sciences.
Neurovalens has approximately 30 employees.
Neurovalens has completed 9 funding rounds, raising a total of $15.76M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Neurovalens include Sharesight, The Bee Corp, iSource Group, Flora & Fauna, SEIKK. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurovalens and Sharesight are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neurovalens and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy